Surface Neutralization System - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Surface Neutralization System
A new, robust method for protein elution from ceramic hydroxyapatite.

Pharmaceutical Technology
Volume 35, Issue 9, pp. 66-72


1. L.J. Cummings, T. Ogawa, and P. Tunón, "CHT Ceramic Hydroxyapatite: New Life for an Old Chromatographic Technique," Bulletin No. 1927 Rev. B (Bio-Rad Laboratories, Hercules, CA, 2005).

2. P. Yachelini, I. Falk, and K. Eichmann, J. Immunol. 145 (5), 1382–1389 (1990).

3. K. Schott et al., J. Biol. Chem. 265 (8), 4204–4209 (1990).

4. C.W. Mahoney, A. Azzi, and K.P. Huang, J. Biol. Chem. 265 (10), 5424–5428 (1990).

5. A.C. Newton and D.E. Koshland Jr., Biochemistry 29 (28), 6656–6661 (1990).

6. B.R. Ganong, Biochemistry 29 (29), 6904–6910 (1990).

7. L.J. Cummings, M.A. Snyder, and K. Brisack, Meth. Enzymol. 463, 387–404 (2009).

8. K. Y. Kwon et al., J. Phys. Chem. Lett. C, 113 (9), 3369–3372 (2009).

9. L. Dattolo, E.L. Keller and G. Carta, J. Chrom. A. 1217 (48), 7573–7578 (2010).

10. M.A. Snyder, presentation at The Fifth Hydoxyapatite Conference (Rottach-Egern, Germany, 2009).

11. L.J. Cummings, presentation at The Fifth Hydoxyapatite Conference (Rottach-Egern, Germany, 2009).

12. CHT Ceramic Hydroxyapatite Instruction Manual, Bulletin LIT611 Rev. E (Bio-Rad Laboratories, Hercules, CA, 2006).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here